Navigation Links
Molecular Signatures in Post-Mortem Brain Tissue of Younger Individuals at High Risk for Alzheimer's Disease
Date:6/2/2010

While the majority of Alzheimer’s researchers focus their attention on the classic pathological signs of the mind-robbing disease – the plaques and tangles --- scientists at The Feinstein Institute for Medical Research have new evidence that there are molecular hints of trouble in the brains of people decades before these signs lay claim in the brain.

Manhasset, NY (Vocus) May 24, 2010 -- While the majority of Alzheimer’s researchers focus their attention on the classic pathological signs of the mind-robbing disease – the plaques and tangles --- scientists at The Feinstein Institute for Medical Research have new evidence that there are molecular hints of trouble in the brains of people decades before these signs lay claim in the brain.

Concepcion Conejero-Goldberg, MD, PhD, and her colleagues have an interest in prevention and thus headed back in time to younger adults who carry a risk gene for Alzheimer’s disease called APOE4. They were hoping to find molecular differences in the brains of people with one or two copies of the APOE4 gene and those who do not carry a copy of the risk gene. Having one copy increases the odds of developing Alzheimer’s three to four times more than people without the genetic variant. They were able to obtain brain tissue from young to middle age adults who died from a variety of causes. They choose tissue from two different brain areas, one that is hard hit by Alzheimer’s (middle temporal gyrus) and one that is not (primary somatosensory cortex). Then they sampled brain tissue from the cerebellum to find out whether the person had been born with an APOE4 gene or not. They had tissue from 41 people who had died on average around 42 years old and no one in the bunch had any pathological signs of Alzheimer’s – at least no plaques and tangles.
   
“We wanted to know whether young people can give us a lead on the development of the disease,” said Dr. Conejero-Goldberg. Once they had the human brain tissue and the genotype of the people whose lives were cut short for a variety of reasons they set out to conduct microarray gene expression studies of the tissue itself. Did having an apoE4 genotype have an impact on the genetic expression of the specific tissue and was the tissue that gets destroyed by the illness molecularly different than the tissue that remains healthy until the very end of the illness?
   
The findings of the study were published in Molecular Psychiatry.
   
They found 70 gene transcripts that differed significantly between the two groups, those with APOE4 and those without. And there were regional differences in the expression of APOE4 itself. Some of the genes are known to be involved with pathways that regulate mitochondrial function, calcium regulation and cell-cycle reentry. The differences in the regulation of the genes between the APOE4 carriers and non-APOE4 carriers and the fact that the changes were observed in the tissue hard hit by Alzheimer’s suggests to these scientists that these molecular hits could be working for a lifetime to set in motion a disease in old age that wipes away memories and so much more. On the contrary, changes in the spared brain area may be neuroprotective.
   
“Our findings tell us that something is going on in the brains of at-risk people very early on, decades before the plaques and tangles begin to appear,” said Dr. Conejero-Goldberg, part of the Litwin-Zucker Research Center for the Study of Alzheimer's Disease. Her collaborators outside of the Feinstein include researchers from the National Institute of Mental Health and Albert Einstein College of Medicine.
   
None of the genes that they identified were involved with the classical Alzheimer’s pathway that leads to amyloid plaques and tau tangles. “These findings may give us clues why some brains are more susceptible to Alzheimer’s than others,” the Feinstein scientist said. Also, the identification of genes that damage pathways also opened the door to genes that may protect the brain against Alzheimer’s.

Contact: Jamie Talan, science writer-in-residence
516-562-1232

###

Read the full story at http://www.prweb.com/releases/Alzheimers-Disease/Feinstein-Institute/prweb4041684.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Molecular imaging and CT colonography team up to bring comfort to patients
2. Acupunctures molecular effects pinned down
3. Salt Lake City proclaims Molecular Imaging Days during SNMs Annual Meeting in June
4. Scientists discover the molecular heart of collective behavior
5. News from Molecular Medicine
6. Molecular marker could help spot pancreatic cancer early
7. Molecular discovery points to new therapies for brain tumors
8. USC researchers discover new molecular subtype of brain cancer
9. The Association for Molecular Pathology celebrates ruling in DNA patent case
10. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
11. SNMs Conjoint Mid-Winter Meetings continue to advance molecular imaging
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Molecular Signatures in Post-Mortem Brain Tissue of Younger Individuals at High Risk for Alzheimer's Disease 
(Date:9/19/2017)... ... , ... MelaKids, a Laredo-based company, has introduced a new concept for children’s ... gives us a full supply of melanin – in the back of the eye ... pigment; however, around the age of thirty, we develop a yellow-brown pigment in the ...
(Date:9/19/2017)... , ... September 19, 2017 , ... The Workgroup ... of health IT to create efficiencies in healthcare information exchange and a trusted advisor ... of their latest industry white paper, entitled Barriers to Adoption of the ERA ...
(Date:9/19/2017)... ... ... Public outrage over the toxins that exist in tap water and the lack ... itself to research, develop and ultimately supply consumers with healthy drinking water alternatives. Vitev ... alkaline water technologies, water filtration systems, and consumer education. , ...
(Date:9/19/2017)... ... September 19, 2017 , ... Bone Solutions Inc. (BSI), an ... orthopedic medical device, OsteoCrete®. OsteoCrete® bone void filler is designed to assist with ... magnesium, a critical property for bone health and development. , “We’re excited to ...
(Date:9/19/2017)... ... September 19, 2017 , ... Ron Norman, CEO of Team Decades, ... of making a distinct rather than generic impression in the job market if one ... a stack of resumes knows that the first impression they give off is not ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... Sept. 6, 2017   PDI , a leader in ... host an educational session focused on the role of ... prevention at the 2017 Annual Scientific Meeting of the ... place at the Phoenix Convention ... Sept. 16-19, will also feature PDI,s Prevantics® Device ...
(Date:9/6/2017)... 2017 Eli Lilly and Company (NYSE: ... data for galcanezumab and lasmiditan, two investigational treatments for ... Society (IHC) taking place Sept. 7-10 in ... new, long-term data from an open-label study evaluating the ... mg and 240 mg) for the prevention of migraine. ...
(Date:9/5/2017)... NEWTOWN, Pa. , Sept. 5, 2017  Xyntek Inc. has announced another ... opened a new Midwest office to meet the growing demands of customer engagements ... Xyntek's new Midwest office is located at ... ... demands of customer engagements regionally. ...
Breaking Medicine Technology: